Skip to content
Abiomed logo — Recovering hearts. Saving lives.

Abiomed

Recovering hearts. Saving lives.

Founded 1981 United States Danvers, United States 2403 employees Post-IPO Equity Health Care, Medical Devices

General Information

Company Name Abiomed
Founded Year 1981
Location United States Danvers, United States
Founders / Decision Makers
Team member
Employees 2403
Industries Health Care, Medical Devices
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Abiomed. To contact Abiomed, visit abiomed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Abiomed compare?

A PDF of Abiomed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Abiomed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Abiomed

Abiomed is a health care company with the slogan "Recovering hearts. Saving lives." Founded in 1981, the company is based in Danvers, Massachusetts, United States. Abiomed, Inc., is a subsidiary of Johnson & Johnson MedTech, and it is renowned for providing innovative medical technology for circulatory support and oxygenation. Their products are designed to allow the heart to recuperate by enhancing blood flow or providing adequate oxygenation for individuals in respiratory failure.

The most recent significant investment in Abiomed was a post-IPO equity investment on 29 December 2011. This investment was made by Essex Woodlands Healthcare Partners, emphasizing the confidence placed in the company's innovative medical technology and its potential for growth and market impact.

As Abiomed continues to make strides in the field of medical technology, the company's commitment to saving lives and improving patient outcomes positions it as a key player in the health care industry, with potential for further expansion and innovation in the forthcoming years. For additional information, interested parties can visit www.abiomed.com.

It's important to note that when considering any medical technology investment, in addition to the potential for growth and innovation, ensuring safety and efficacy is paramount. Interested stakeholders should refer to the Important Safety Info provided by the company to gain comprehensive insights into their products and practices (https:\/\/bit.ly\/39kvb47).

Business keywords: circulatory support, oxygenation, heart recovery, blood flow improvement, respiratory support, cardiac catheterization, interventional cardiology, heart surgery, hemodynamic support, angioplasty, cardiovascular medical device, cardiac surgery, mechanical circulatory support, Johnson & Johnson MedTech

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed 1
Essex Woodlands Healthcare Partners
29 Dec 2011

Abiomed Alternatives & Competitors

View All Alternatives
Abiomed vs
SpectraWAVE, Inc.
SpectraWAVE, Inc. United States

Improving coronary artery disease outcomes with optical and computational insights.

Series B
56 employees
Biotechnology, Health Care
Abiomed vs

Pioneering advanced cardiovascular medical devices for life-saving heart treatments.

Private Equity
201-500 employees
Health Care, Manufacturing
Abiomed vs

Our Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysio...

Series B
116 employees
AI, Health Care

FAQ About Abiomed

Recovering hearts. Saving lives.
Abiomed was founded in 1981.
Abiomed is headquartered in Danvers, United States.
Abiomed operates in Health Care and Medical Devices. Its work centres on circulatory support, oxygenation, heart recovery and blood flow improvement.
Abiomed has approximately 2403 employees.
Abiomed has completed 1 funding round. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Abiomed include SpectraWAVE, Inc., Relisys, Volta Medical, CircuLite, Saranas. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abiomed and SpectraWAVE, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Abiomed, https://bouncewatch.com/company/abiomed, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout